Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuwan C Hettige

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Pediatrics|December 12, 2019
<i>FOXG1</i> Dose in Brain DevelopmentNuwan C Hettige, Carl Ernst
Psychopharmacology|January 10, 2014
Does a history of suicide attempt predict higher antipsychotic dosage in schizophrenia?Nuwan C Hettige, James L Kennedy, Vincenzo De Luca
Pharmacogenomics|November 28, 2017
Validating a research ethnicity questionnaire using genomic markersNuwan C Hettige, Ali Bani-Fatemi, Vincenzo De Luca
The International Journal of Neuropsychopharmacology|October 18, 2017
Strategies to Advance Drug Discovery in Rare Monogenic Intellectual Disability SyndromesNuwan C Hettige, Karla Manzano-Vargas, Malvin Jefri, et al.
CNS Spectrums|May 25, 2017
A biopsychosocial evaluation of the risk for suicide in schizophreniaNuwan C Hettige, Ali Bani-Fatemi, Isaac Sakinofsky, et al.
Schizophrenia Research|January 19, 2016
Polygenic risk score prediction of antipsychotic dosage in schizophreniaNuwan C Hettige, Christopher B Cole, Sarah Khalid, et al.
BMC Psychiatry|February 11, 2017
Assessing the risk for suicide in schizophrenia according to migration, ethnicity and geographical ancestryNuwan C Hettige, Ali Bani-Fatemi, James L Kennedy, et al.
Pharmacogenomics|January 19, 2016
Candidate gene analysis of pharmacodynamic targets for antipsychotic dosageNuwan C Hettige, Gustavo H F de Moraes, James L Kennedy, et al.
Bio-Protocol|March 3, 2021
Differentiation of Human Induced Pluripotent Stem Cells (iPSCs) into an Effective Model of Forebrain Neural Progenitor Cells and Mature NeuronsScott Bell, Nuwan C Hettige, Heika Silveira, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 13, 2014
Use of candidate gene markers to guide antipsychotic dosage adjustmentNuwan C Hettige, Clement Zai, Monica Hazra, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Pediatrics|December 12, 2019
<i>FOXG1</i> Dose in Brain DevelopmentNuwan C Hettige, Carl Ernst
Psychopharmacology|January 10, 2014
Does a history of suicide attempt predict higher antipsychotic dosage in schizophrenia?Nuwan C Hettige, James L Kennedy, Vincenzo De Luca
Pharmacogenomics|November 28, 2017
Validating a research ethnicity questionnaire using genomic markersNuwan C Hettige, Ali Bani-Fatemi, Vincenzo De Luca
The International Journal of Neuropsychopharmacology|October 18, 2017
Strategies to Advance Drug Discovery in Rare Monogenic Intellectual Disability SyndromesNuwan C Hettige, Karla Manzano-Vargas, Malvin Jefri, et al.
CNS Spectrums|May 25, 2017
A biopsychosocial evaluation of the risk for suicide in schizophreniaNuwan C Hettige, Ali Bani-Fatemi, Isaac Sakinofsky, et al.
Schizophrenia Research|January 19, 2016
Polygenic risk score prediction of antipsychotic dosage in schizophreniaNuwan C Hettige, Christopher B Cole, Sarah Khalid, et al.
BMC Psychiatry|February 11, 2017
Assessing the risk for suicide in schizophrenia according to migration, ethnicity and geographical ancestryNuwan C Hettige, Ali Bani-Fatemi, James L Kennedy, et al.
Pharmacogenomics|January 19, 2016
Candidate gene analysis of pharmacodynamic targets for antipsychotic dosageNuwan C Hettige, Gustavo H F de Moraes, James L Kennedy, et al.
Bio-Protocol|March 3, 2021
Differentiation of Human Induced Pluripotent Stem Cells (iPSCs) into an Effective Model of Forebrain Neural Progenitor Cells and Mature NeuronsScott Bell, Nuwan C Hettige, Heika Silveira, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 13, 2014
Use of candidate gene markers to guide antipsychotic dosage adjustmentNuwan C Hettige, Clement Zai, Monica Hazra, et al.
Pageof 2